P32 Jak inhibitors Tofacitinib and Ruxolitinib do not improve functional deficits in dystrophin-deficient mdx mice Conference Poster (Faculty180)

cited authors

  • Bosco, C; Uaesoontrachoon, K; Srinivassane, S; Rowsell, J; Elustondo, P; Mackinnon, A; Nagaraju, K; Peterson, J

authors

publication date

  • 2023

presented at event